1. Association between liver enzymes and metabolic syndrome in Canadian adults: results from the Canadian health measures survey - cycles 3 &4

   • Luan Manh Chu
   • Chandima Karunanayake
   • Punam Pahwa

   Research article 17 September 2022 Pages: 1699 - 1708

   

2. Genetic variation in DPP-IV gene linked to predisposition of T2DM: A case control study

   • Archna Bhargave
   • Kiran Devi
   • Ranjan Gupta

   Research article 12 October 2022 Pages: 1709 - 1716

   

3. Experimental and molecular docking studies of quercetin and vitamin E with diabetes-associated mitochondrial-ATPase as anti-apoptotic therapeutic strategies

   • Oluwatoyin O. Ojo
   • Titilayo Ogunleke
   • Olufunso O. Olorunsogo

   Research article 30 September 2022 Pages: 1717 - 1729

   

4. Primaquine activates Keratin 7 to treat diabetes and its complications

   • Tongyu Wu
   • Chun Li
   • Xinping Chen

   Research article 29 September 2022 Pages: 1731 - 1741

   

5. Is elevated ALT associated with lifestyle risk factors? A population-based survey

   • Pargol Balali
   • Maryam Nasserinejad
   • Alireza Delavari

   Research article 12 October 2022 Pages: 1743 - 1751

   

6. What I felt as a diabetes fatigue survivor: a phenomenology study

   • Kusnanto Kusnanto
   • Rifky Octavia Pradipta
   • Sirikanok Klankhajhon

   Research article 20 October 2022 Pages: 1753 - 1762

7. Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview

   • Nastaran Hadizadeh
   • Mousa Naderi
   • Ehsan Hashemi

   Review article 22 July 2022 Pages: 1763 - 1783

8. Effect of Citrullus colocynthis on glycemic factors and lipid profile in type II diabetic patients: a systematic review and meta-analysis

   • Ali Jafarizadeh
   • Seyed Amin Raeisi
   • Mojgan Mirghafourvand

   Review article 05 August 2022 Pages: 1785 - 1795

   

9. The beneficial role of Hepcidin peptide inhibitor in improved the symptoms of COVID-19 in diabetics: anti-inflammatory and potential therapeutic effects

   • Motahareh Zeinivand
   • Nida jamali-Raeufy
   • Fahime Zavvari

   Review article 06 July 2022 Pages: 1797 - 1807

   

10. Early life exposure to famine and risk of dyslipidemia in adults: a systematic review and Meta-analysis

    • Getachew Arage
    • Tefera Belachew
    • Kalkidan Hassen Abate

    Review article 09 June 2022 Pages: 1809 - 1817

    

11. MicroRNAs as biomarkers for monitoring cardiovascular changes in Type II Diabetes Mellitus (T2DM) and exercise

    • Volga M Saini
    • Kaitlyn R. Liu
    • Ananya Gupta

    Review article Open access 07 July 2022 Pages: 1819 - 1832

    

12. Therapeutic effects of dietary antioxidative supplements on the management of type 2 diabetes and its complications; umbrella review of observational/trials meta-analysis studies

    • Ozra Tabatabaei-Malazy
    • Maryam Peimani
    • Bagher Larijani

    Review article 20 June 2022 Pages: 1833 - 1859

    

13. The effect of exercise therapy on balance in patients with diabetic peripheral neuropathy: a systematic review

    • Narges Jahantigh Akbari
    • Sedigheh Sadat Naimi

    Review article 04 July 2022 Pages: 1861 - 1871

    

14. Role of butyrogenic Firmicutes in type-2 diabetes

    • Meenu Mariya James
    • Namrata Pal
    • Manoj Kumar

    Review article 14 July 2022 Pages: 1873 - 1882

    

15. Efficacy of the holistic, psychonutritional approach of Centro DAI e Obesità di Città della Pieve in the management of type 2 diabetes among patients with obesity and dysfunctional eating

    • Luisa Barana
    • Georgia Colleluori
    • Simone Pampanelli

    Review article 22 July 2022 Pages: 1883 - 1893

    

16. A Meta-analysis of ADIPOQ rs2241766 polymorphism association with type 2 diabetes

    • Yeganeh Hamidi
    • Sahar Saki
    • Sanaz Pashapour

    Review article 12 July 2022 Pages: 1895 - 1901

    

17. Recent advances in molecular biology of metabolic syndrome pathophysiology: endothelial dysfunction as a potential therapeutic target

    • Basheer Abdullah Marzoog

    Review article 31 August 2022 Pages: 1903 - 1911

18. Epidemiology of diabetes in Iran: A scoping review of studies published during 2015–2019

    • Fatemeh Gharishvandi
    • Hamed Moheimani
    • Noushin Fahimfar

    Review article 04 August 2022 Pages: 1913 - 1921

    

19. Tryptophan and serotonin levels as potent biomarkers in diabetes mellitus complications: a new approach of diagnostic role

    • Kamyar Khoshnevisan
    • Maryam Chehrehgosha
    • Amir Mohammad Meftah

    Review article 18 July 2022 Pages: 1923 - 1934

    

20. The relationship between GAD65 autoantibody and the risk of T1DM onset

    • Elham Keshavarzi
    • Behnoud Baradaran Noveiry
    • Nima Rezaei

    Review article 05 August 2022 Pages: 1935 - 1942

21. Association of lipid accumulation product with type 2 diabetes mellitus, hypertension, and mortality: a systematic review and meta-analysis

    • Shaghayegh Khanmohammadi
    • Hamed Tavolinejad
    • Ali Vasheghani-Farahani

    Review article 30 August 2022 Pages: 1943 - 1973

    

22. Association of fat mass and obesity-associated (FTO) gene polymorphisms with non-communicable diseases (NCDs) in the Iranian population: A systematic review of observational studies

    • Zahra Hoseini Tavassol
    • Seyed Mohammad Mousavi
    • Shirin Hasani-Ranjbar

    Review article 24 October 2022 Pages: 1975 - 1989

23. Safety and effectiveness of newer antidiabetic medications during Ramadan fasting and safety of Ramadan fasting after bariatric surgery

    • Musaab Ahmed
    • Safaa Badi
    • Mohamed H. Ahmed

    Review article 24 October 2022 Pages: 1991 - 2004

    

24. SARS-CoV-2 infection may enhance the adverse effect of thyroid disturbance on climacteric symptoms

    • Marzieh Saei Ghare Naz
    • Fahimeh Ramezani Tehrani

    Letter to the Editor 24 July 2022 Pages: 2005 - 2006

25. Letter to the editor about the article entitled “Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis”

    • Ehsan Shahrestanaki
    • Hadith Rastad

    Letter to the Editor 14 September 2022 Pages: 2007 - 2007

26. Medical management of pancreatic neuroendocrine tumors in patients with MEN 1: case report

    • Mohammad Reza Mohajeri-Tehrani
    • Mahbube Ebrahimpur
    • Mohammad Behgam Shadmehr

    Case report 29 June 2022 Pages: 2009 - 2011

27. Post COVID-19 neuropsychiatric complications and therapeutic role for TNF-α inhibitors: a case series study

    • Gita Shafiee
    • Tohid Arastou
    • Seyed Masoud Arzaghi

    Case report 15 October 2022 Pages: 2013 - 2016

28. Mapping evidence of Iran diabetes research: protocol for a scoping review

    • Shahnaz Esmaeili
    • Fatemeh Bandarian
    • Ensieh Nasli-Esfahani

    Study Protocol 06 July 2022 Pages: 2017 - 2021

29. The OPTIMISE study protocol: a multicentre optimisation trial comparing continuous glucose monitoring, snacking habits, sleep extension and values-guided self-care interventions to improve glucose time-in-range in young people (13–20 years) with type 1 diabetes

    • Shelley Rose
    • Jillian J. Haszard
    • Sara E. Styles

    Study Protocol Open access 11 August 2022 Pages: 2023 - 2033

    

30. Study Protocol titled as “Effectiveness of neural mobilization in improving the ankle ROM and plantar pressure distribution in patients with diabetic peripheral neuropathy: A single group, pre post, quasi experimental study protocol”

    • Madhu Goyat
    • Akanksha Saxena
    • Manu Goyal

    Study Protocol 15 August 2022 Pages: 2035 - 2041

    

31. Correction to: Intestinal Microbiota Composition in Iranian Diabetic, Pre-diabetic and Healthy Individuals

    • Farahnaz Ghaemi
    • Abolfazl Fateh
    • Seyed Davar Siadat

    Correction 15 October 2022 Pages: 2043 - 2043